HLS Therapeutics, Inc. (HLS.TO)
4.09
-0.11
(-2.62%)
CAD |
TSX |
Oct 09, 16:00
HLS Therapeutics Market Cap : 127.89M for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 09, 2026 | 127.89M |
| October 08, 2026 | 131.33M |
| October 07, 2026 | 132.90M |
| October 06, 2026 | 131.33M |
| October 05, 2026 | 131.64M |
| October 02, 2026 | 121.01M |
| October 01, 2026 | 121.64M |
| September 30, 2026 | 131.33M |
| September 29, 2026 | 124.76M |
| September 28, 2026 | 125.08M |
| September 25, 2026 | 125.70M |
| September 24, 2026 | 123.20M |
| September 23, 2026 | 123.51M |
| September 22, 2026 | 123.83M |
| September 21, 2026 | 124.14M |
| September 18, 2026 | 122.26M |
| September 17, 2026 | 124.76M |
| September 16, 2026 | 126.02M |
| September 15, 2026 | 127.89M |
| September 14, 2026 | 129.77M |
| September 11, 2026 | 121.95M |
| September 10, 2026 | 116.63M |
| September 09, 2026 | 117.26M |
| September 08, 2026 | 118.20M |
| September 04, 2026 | 115.70M |
| Date | Value |
|---|---|
| September 03, 2026 | 112.57M |
| September 02, 2026 | 112.88M |
| September 01, 2026 | 117.26M |
| August 31, 2026 | 117.26M |
| August 28, 2026 | 118.51M |
| August 27, 2026 | 115.70M |
| August 26, 2026 | 114.13M |
| August 25, 2026 | 120.07M |
| August 24, 2026 | 115.38M |
| August 21, 2026 | 117.26M |
| August 20, 2026 | 123.20M |
| August 19, 2026 | 121.01M |
| August 18, 2026 | 121.95M |
| August 17, 2026 | 121.95M |
| August 14, 2026 | 121.95M |
| August 13, 2026 | 121.01M |
| August 12, 2026 | 124.45M |
| August 11, 2026 | 119.76M |
| August 10, 2026 | 122.58M |
| August 07, 2026 | 126.02M |
| August 06, 2026 | 125.09M |
| August 05, 2026 | 128.85M |
| August 04, 2026 | 128.85M |
| July 31, 2026 | 131.35M |
| July 30, 2026 | 131.35M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Bausch Health Cos., Inc. | 3.231B |
| Cipher Pharmaceuticals, Inc. | 346.91M |
| BioSyent, Inc. | 194.49M |
| Revive Therapeutics Ltd. | 10.89M |
| Knight Therapeutics, Inc. | 1.064B |
Market Cap Related Metrics
| PS Ratio | 1.647 |
| Price to Book Value | 1.632 |
| Price to Free Cash Flow | 5.858 |
| Price | 4.09 |
| Earnings Yield | -9.22% |